Clinical trials recruiting for Diabetes Mellitus

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft Patients or Post Percutaneous Coronary Intervention Patients
  NCT06615609 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Fruit and Vegetable Prescription Program
  NCT06107816 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
  NCT07238556 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 64 Years · Sex: All (male and female) · 6 locations
• A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus
  NCT03937453 · Phase: Not specified · Ages: 50 Years and older · Sex: All (male and female) · 2 locations
• A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
  NCT06623396 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
  NCT05970237 · Phase: Not specified · Ages: 19 Years and older · Sex: All (male and female) · 2 locations
• A Twelve-Week Pilot Study Evaluating the Usability and Preliminary Effects of SugarVita 2.0 in Adults With Type 2 Diabetes
  NCT07812623 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
  NCT07533175 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 74 locations
• Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome
  NCT07173062 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years and older · Sex: All (male and female) · 1 location
• American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
  NCT04185844 · Phase: Not specified · Ages: 21 Years to 80 Years · Sex: All (male and female) · 3 locations
• Antidiabetic Effect of Olive Pomace Oil
  NCT06723886 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 70 Years · Sex: All (male and female) · 1 location
• Arizona CEAL: Linking Social Care With Healthcare Systems to Address SDOH
  NCT07799961 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Automated Insulin Delivery in Adults With Advanced Kidney Disease
  NCT06463483 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
  NCT07403669 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 10 locations
• Care Transitions App for Patients With Multiple Chronic Conditions
  NCT06051058 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years and older · Sex: All (male and female) · 2 locations
• Change of Adipose Tissues and Triglyceride After Bariatric Surgery or Life-style Intervention
  NCT03875625 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 65 Years · Sex: All (male and female) · 2 locations
• Changes in Person-reported Outcomes and Behavior Using the Accu-Chek SmartGuide CGM and Predict App
  NCT07814508 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
  NCT06674980 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
  NCT05955339 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Comparison of Intensive Versus Standard Care & Education for Dyslipidemia in Hypertension and Diabetes Patients
  NCT07045623 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 80 Years · Sex: All (male and female) · 1 location
• Continuous Glucose Monitoring (CGM) in an Underserved Population
  NCT07135531 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF)
  NCT05174052 · Phase: Phase 3 · Ages: 18 Years to 85 Years · Sex: All (male and female) · 1 location
• Deep Phenotyping of Peripheral Blood Cells and Circulating Factors in Metabolic Diseases
  NCT06396871 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Diabetic Neuropathy in Spinal Cord Stimulator Patients
  NCT04687215 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Domestication and Implementation of the PEN-Plus Clinical Model in the Zambian Health System
  NCT07753681 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• ED Diabetes Screening and Outpatient Care - Aim 3
  NCT05899023 · Phase: Not applicable (e.g. observational or device study) · Ages: 20 Years to 70 Years · Sex: All (male and female) · 1 location
• EMPOWER-1: A Multi-site Clinical Cohort Research Study to Reduce Health Inequality
  NCT03987633 · Phase: Not specified · Ages: 6 Years and older · Sex: All (male and female) · 2 locations
• Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
  NCT06124586 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Early Tracking of Childhood Health Determinants (ETCHED) Study
  NCT03481829 · Phase: Not specified · Ages: 1 Day to 99 Years · Sex: All (male and female) · 1 location
• Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers
  NCT05610865 · Phase: Phase 1 · Ages: 20 Years to 60 Years · Sex: All (male and female) · 1 location
• Environment, Inflammation and Metabolic Diseases Study
  NCT07512609 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
  NCT06871293 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Examining Digital Health Care Delivery Models Through Medicaid Collaborative
  NCT05555095 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
  NCT06724406 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Feasibility Study to Evaluate an Intravascular Blood Continuous Glucose Sensor
  NCT06764069 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 75 Years · Sex: All (male and female) · 1 location
• Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
  NCT07386340 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Glycemic Control With Triple Pathway Approach Through Empagliflozin, Linagliptin and Metformin Combination
  NCT06862739 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations
• Goal Commitment and Proactive Health Behavior in Chronic Disease Patients
  NCT07552571 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years and older · Sex: All (male and female) · 1 location
• Impact GLP-1 Agonists Following Bariatric
  NCT06132477 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Implementation and Evaluation of a Pharmacist-led Diabetes Care Pathway in Alberta Community Pharmacies
  NCT07339852 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes
  NCT06557317 · Phase: Not applicable (e.g. observational or device study) · Ages: 12 Years to 18 Years · Sex: Female · 1 location
• Inflammation, Diabetes, Ethnicity and Obesity Cohort
  NCT03022682 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Integrated Approach in Frail Older People with Atrial Fibrillation
  NCT06775028 · Phase: Not applicable (e.g. observational or device study) · Ages: 65 Years and older · Sex: All (male and female) · 50 locations
• Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome
  NCT06703788 · Phase: Phase 1, Phase 2 · Ages: 20 Years to 75 Years · Sex: All (male and female) · 1 location
• Investigating How NNC0487-0111 Regulates Insulin of Adults With Type 2 Diabetes
  NCT07535307 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• Metabolic Phenotyping and Follow-Up of Patients With and Without Diabetes After New Onset of STEMI
  NCT05046483 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes
  NCT07420634 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: All (male and female) · 1 location
• NYSCF Scientific Discovery Biobank
  NCT06203106 · Phase: Not specified · Ages: 30 Days and older · Sex: All (male and female) · 1 location
• Optimized Care of People With Diabetes and Foot Complication in Primary Care
  NCT05692778 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
  NCT06694012 · Phase: Not specified · Ages: 20 Years and older · Sex: All (male and female) · 1 location
• Pancreatic Cancer and Diabetes Mellitus
  NCT06585072 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Paraoxonase and HDL Qualities in Glycaemia and Inflammation
  NCT02169518 · Phase: Not specified · Ages: 20 Years to 75 Years · Sex: All (male and female) · 1 location
• Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and Identification of Its Associated Factors.
  NCT07392437 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery
  NCT07011147 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 89 Years · Sex: All (male and female) · 2 locations
• Randomised Trial of Dual Device Treatment Involving Drug-coated Balloon Angioplasty and Drug-eluting Stent Implantation Compared to Single Device Treatments in Patients With Diabetes Mellitus
  NCT07303439 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Remote Ischemic Preconditioning in Type 2 Diabetic Patients Undergoing CABG
  NCT06977230 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 85 Years · Sex: All (male and female) · 2 locations
• Retinal Vascular Manifestations in Patients With Common Internal Diseases on OCTA Tomography Angiography
  NCT05644548 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases
  NCT05476627 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• SPYRAL GEMINI Pilot Study
  NCT06907147 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · 18 locations
• Safety and Efficacy of Fecal Microbiota Transplantation
  NCT04014413 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• Sex, Psychopharmacology, and Diabetes
  NCT05951660 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With Uncontrolled Hypertension
  NCT07115953 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 21 locations
• Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and Subcutaneous, in a Real-world Setting at 3 Months, 6 Months, and 1 Year of Follow-up, Quantifying the Reduction in Glycated Hemoglobin
  NCT07621419 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Surveillance of Pancreatic Health After Diabetes Diagnosis
  NCT06803771 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 84 Years · Sex: All (male and female) · 31 locations
• Swiss Diabetes Registry - SwissDiab Study
  NCT01179815 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• Taining Golden Lake Comprehensive Chronic Disease Management Initiative
  NCT07308314 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Bialystok Bariatric Surgery Study
  NCT04634591 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The Daytime Circadian Rhythm in Exhaled Volatile Organic Compounds in People Living Without and Diabetes
  NCT05984979 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• The PACT (Patient Activation Through Conversations) Study
  NCT06444074 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 64 Years · Sex: All (male and female) · 3 locations
• Uppsala Self-Screening of Cardiovascular Health
  NCT07614659 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 75 Years · Sex: All (male and female) · 3 locations
• Validation of Insulin Dose Prediction Model Based on Artificial Intelligence Algorithm
  NCT07066891 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Diabetes Mellitus often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Diabetes Mellitus trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.